12:00 AM
 | 
Mar 04, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Astellas sales and marketing update

Astellas' Astellas Pharma Europe Ltd. launched Betmiga mirabegron in the U.K. to treat overactive...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >